Index | FTSE 100 |
Investment focus | Equity, United Kingdom |
Fund size | GBP 2,202 m |
Total expense ratio | 0.07% p.a. |
Replication | Physical (Full replication) |
Legal structure | ETF |
Strategy risk | Long-only |
Sustainability | No |
Fund currency | GBP |
Currency risk | Currency unhedged |
Volatility 1 year (in GBP) | 9.34% |
Inception/ Listing Date | 26 January 2010 |
Distribution policy | Accumulating |
Distribution frequency | - |
Fund domicile | Ireland |
Fund Provider | iShares |
Fund Structure | Open-ended Investment Company (OEIC) |
UCITS compliance | Yes |
Administrator | State Street Fund Services (Ireland) Limited |
Investment Advisor | |
Custodian Bank | State Street Custodial Services (Ireland) Limited, Dublin 2 |
Revision Company | Deloitte |
Fiscal Year End | 31 July |
Swiss representative | BlackRock Asset Management Schweiz AG |
Swiss paying agent | State Street Bank International GmbH, Munich, Zurich Branch |
Germany | 30% tax rebate |
Switzerland | ESTV Reporting |
Austria | Tax Reporting Fund |
UK | UK Reporting |
Indextype | Total return index |
Swap counterparty | - |
Collateral manager | Bank of New York Mellon|Euroclear|JP Morgan|State Street Bank |
Securities lending | Yes |
Securities lending counterparty | Barclays Bank Plc|Barclays Capital Securities Ltd.|BNP Paribas Arbitrage SNC|BNP Paribas SA|Citigroup Global Markets Ltd|Citigroup Inc|Credit Suisse Securities (Europe) Ltd.|Deutsche Bank AG|Goldman Sachs International|HSBC Bank Plc|J.P. Morgan Securities Plc|JP Morgan Chase & Co|Macquarie Bank Limited|Merrill Lynch International|Morgan Stanley & Co. International Plc|Nomura International Plc|Skandinaviska Enskilda Banken AB|Societe Generale SA|The Bank of Nova Scotia|UBS AG |
AstraZeneca PLC | 8.49% |
Shell Plc | 7.46% |
HSBC Holdings Plc | 6.06% |
Unilever Plc | 5.83% |
RELX | 3.21% |
BP Plc | 3.16% |
GSK Plc | 2.96% |
Diageo Plc | 2.83% |
Rio Tinto Plc | 2.77% |
British American Tobacco plc | 2.66% |
United Kingdom | 91.67% |
Switzerland | 2.81% |
Ireland | 2.01% |
Other | 3.51% |
Financials | 18.78% |
Consumer Staples | 17.59% |
Industrials | 14.05% |
Health Care | 12.28% |
Other | 37.30% |
YTD | +8.64% |
1 month | -2.49% |
3 months | -1.18% |
6 months | -2.01% |
1 year | +12.32% |
3 years | +25.48% |
5 years | +33.32% |
Since inception (MAX) | +162.03% |
2023 | +7.77% |
2022 | +4.62% |
2021 | +18.28% |
2020 | -11.62% |
Volatility 1 year | 9.34% |
Volatility 3 years | 12.95% |
Volatility 5 years | 17.23% |
Return per risk 1 year | 1.32 |
Return per risk 3 years | 0.61 |
Return per risk 5 years | 0.34 |
Maximum drawdown 1 year | -4.70% |
Maximum drawdown 3 years | -9.35% |
Maximum drawdown 5 years | -34.23% |
Maximum drawdown since inception | -34.23% |
Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
---|---|---|---|---|---|
London Stock Exchange | GBX | CUKX | - - | - - | - |
gettex | EUR | SXRW | - - | - - | - |
Stuttgart Stock Exchange | EUR | SXRW | - - | - - | - |
Euronext Amsterdam | EUR | ISFE | CUKX NA | CUKX.NA | |
London Stock Exchange | GBP | - | CUKX LN IXM035 | CUKX.L IXM035.DE | |
SIX Swiss Exchange | GBP | CSUKX | CSUKX SE IXM035 | CSUKX.S IXM035.DE | |
XETRA | EUR | SXRW | SXRW GY IXM0351 | SXRW.DE IXM0351.DE |
Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
---|---|---|---|---|
iShares Core FTSE 100 UCITS ETF (Dist) | 13,506 | 0.07% p.a. | Distributing | Full replication |
Vanguard FTSE 100 UCITS ETF Distributing | 4,361 | 0.09% p.a. | Distributing | Full replication |
Vanguard FTSE 100 UCITS ETF (GBP) Accumulating | 1,612 | 0.09% p.a. | Accumulating | Full replication |
HSBC FTSE 100 UCITS ETF GBP | 594 | 0.07% p.a. | Distributing | Full replication |
Amundi FTSE 100 UCITS ETF Acc | 316 | 0.14% p.a. | Accumulating | Swap-based |